Related Experiment Video
Updated: May 3, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Potential role of mirtazapine in underweight older adults
Olga Hilas1, Carmela Avena-Woods1
1St. John's University College of Pharmacy and Health Sciences, Queens, New York.
Abstract:
Changes in body weight can affect the overall health of an older patient and should not be considered a normal part of the aging process. In particular, weight loss can lead to numerous adverse health outcomes affecting daily activities, loss of functional status, and increased mortality. Approximately 15% to 20% of older adults experience unintentional weight loss and require intervention to maintain quality of life. Currently, there are no pharmacologic agents indicated to treat unintentional weight loss in older adults; however, several medications may aid by stimulating appetite and/or promoting weight gain. In recent years, mirtazapine has gained attention not only for its antidepressant effects, but also for its potential benefits in underweight patients. This agent has been found to increase appetite and weight in adults compared with placebo and other antidepressants, but further clinical investigation is necessary to determine the role of mirtazapine in the older underweight population.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug Dosing: Geriatric Patients
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

